Filed 24d ago· May 10, 2026
3 days to disclose
Tina Smith
DSenateMinnesota
↓sold
Dexcom
DXCM
$100K-$250K
+2.6% vs S&P 500
Trade dateMay 7, 2026
DexCom, Inc. -
⚑ Healthcare
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.















| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 10, 2026 24d ago | ![]() Tina Smith DSenateMinnesota | ↓sold | Dexcom DXCM DexCom, Inc. - ⚑ Healthcare · Finance | May 7, 2026 3 days to disclose | Flat·+0.0% +2.6% vs S&P 500 | $100K-$250K midpoint $175K |
May 10, 2026 24d ago | ![]() Tina Smith DSenateMinnesota | ↓sold | Dexcom DXCM DexCom, Inc. - ⚑ Healthcare · Finance | Apr 29, 2026 11 days to disclose | Flat·+0.0% +4.0% vs S&P 500 | $100K-$250K midpoint $175K |
Feb 15, 2026 3mo ago | ![]() John Boozman RSenateArkansas | ↑bought | Dexcom DXCM ⚑ Healthcare · Veterans' Affairs | Jan 26, 2026 20 days to disclose | Bad buy·−$64-0.8% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Dexcom DXCM | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Dexcom DXCM | May 8, 2025 45 days to disclose | Bad buy·−$4.8K-14.8% −25.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 9, 2025 11mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Dexcom DXCM | May 15, 2025 25 days to disclose | Bad buy·−$1.2K-15.1% −28.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Dexcom DXCM | Apr 7, 2025 31 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Dexcom DXCM | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Dexcom DXCM | Feb 25, 2025 30 days to disclose | Bad buy·−$1.4K-17.6% −17.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2025 1.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Dexcom DXCM ⚑ Healthcare · Ways and Means | Dec 31, 2024 15 days to disclose | Flat·+0.0% +8.0% vs S&P 500 | $50K-$100K midpoint $75K |
Oct 15, 2023 2.6y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Dexcom DXCM | Sep 15, 2023 30 days to disclose | Flat·+0.0% +12.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 16, 2023 2.7y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Dexcom DXCM | Aug 25, 2023 22 days to disclose | Bad buy·−$2.2K-27.8% −39.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 16, 2022 3.6y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Dexcom DXCM | Sep 15, 2022 31 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Dexcom DXCM ⚑ Healthcare · Ways and Means | Jun 3, 2021 112 days to disclose · 67 past 45-day window | Flat·+0.0% +22.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Dexcom DXCM ⚑ Healthcare · Ways and Means | Jan 9, 2020 623 days to disclose · 578 past 45-day window | price pending | $15K-$50K midpoint $32.5K |